Harpreet S. Dhaliwal - 08 Nov 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Cml Mfg & Supply Chain
Signature
Harpreet S. Dhaliwal, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
08 Nov 2021
Net transactions value
$0
Form type
4
Filing time
01 Feb 2022, 16:41:33 UTC
Previous filing
06 Oct 2021
Next filing
04 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 08 Nov 2021 Common Stock 100,000 $25.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option shall vest on October 1, 2022, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date